ISPE announced today that it will hold its first-ever conference focused on benchmarking and advancing the development of Quality by Design in the biopharmaceutical industry. The two-day event, taking place 10 – 11 April 2013 in San Francisco, CA, will feature workshops and discussions on the industry's progress since the introduction of A-Mab and steps for further adoption of QbD principles. The conference is endorsed by CASSS, a not-for-profit 501 professional scientific society made up of over 4,000 industry, academic and public sector professionals.Read the full story.